Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Development of a bionic system for the simultaneous prediction of the release/absorption characteristics of enteric-coated formulations.

Liu W, He X, Li Z, Gao X, Ma Y, Xun M, Liu C.

Pharm Res. 2013 Feb;30(2):596-605. doi: 10.1007/s11095-012-0905-3. Epub 2012 Nov 8.

PMID:
23135820
2.

Omeprazole--a new formulation.

Armstrong D.

Can J Gastroenterol. 1997 Nov-Dec;11(8):655-6. No abstract available.

PMID:
9459043
3.

In vitro-in vivo correlations for three different commercial immediate-release indapamide tablets.

Yaro P, He X, Liu W, Xun M, Ma Y, Li Z, Shi X.

Drug Dev Ind Pharm. 2014 Dec;40(12):1670-6. doi: 10.3109/03639045.2013.842577. Epub 2013 Oct 8.

PMID:
24102615
4.

Design and in vitro/in vivo evaluation of multi-layer film coated pellets for omeprazole.

He W, Fan LF, Du Q, Xiang B, Li CL, Bai M, Chang YZ, Cao DY.

Chem Pharm Bull (Tokyo). 2009 Feb;57(2):122-8.

5.

Study on dissolution and absorption of four dosage forms of isosorbide mononitrate: level A in vitro-in vivo correlation.

Li ZQ, He X, Gao X, Xu YY, Wang YF, Gu H, Ji RF, Sun SJ.

Eur J Pharm Biopharm. 2011 Oct;79(2):364-71. doi: 10.1016/j.ejpb.2011.04.015. Epub 2011 May 5.

PMID:
21569844
6.

Dissolution of omeprazole from delayed-release solid oral dosage forms.

Farinha A, Bica A, Martins JM, Pais JP.

Drug Dev Ind Pharm. 2000 Jul;26(7):785-90.

PMID:
10872100
7.

Dissolution test for liquid formulations of omeprazole enteric-coated products.

Jang HJ, Kang BC, Shin WG, Lee S.

Ann Pharmacother. 2003 Jan;37(1):150-1. No abstract available.

PMID:
12503954
8.

[Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].

Navarro MA, Raei N, Torres F, Granero L, García-Zaragoza E, Esplugues JV, Esteban Peris J.

Gastroenterol Hepatol. 1998 Feb;21(2):63-70. Spanish.

PMID:
9549180
9.

Application of an in vitro DDASS to evaluate oral absorption of two chemicals simultaneously: establishment of a level A in vitro-in vivo correlation.

Hou J, He X, Xu X, Shi X, Xu Y, Liu C.

Drug Dev Ind Pharm. 2012 Nov;38(11):1305-12. Epub 2012 Feb 1.

PMID:
22296178
10.

In vitro study on capsule formulations of omeprazole containing enteric coated granules.

Pandey VP, Phanindrudu A, Manavalan R, Livingston J.

Boll Chim Farm. 2002 Nov-Dec;141(6):419-22.

PMID:
12577509
11.

Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.

Thomson AB, Kirdeikis P, Lastiwka R, Röhss K, Sinclair P, Olofsson B.

Can J Gastroenterol. 1997 Nov-Dec;11(8):657-60.

PMID:
9459044
14.

In vitro dissolution of proton-pump inhibitor products intended for paediatric and geriatric use in physiological bicarbonate buffer.

Liu F, Shokrollahi H.

Int J Pharm. 2015 May 15;485(1-2):152-9. doi: 10.1016/j.ijpharm.2015.03.008. Epub 2015 Mar 5.

PMID:
25746736
15.

Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.

Shibata H, Yoshida H, Izutsu K, Goda Y.

J Pharm Pharmacol. 2016 Apr;68(4):467-74. doi: 10.1111/jphp.12540. Epub 2016 Mar 28.

PMID:
27019275
16.

Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.

Varum FJ, Merchant HA, Goyanes A, Assi P, Zboranová V, Basit AW.

Int J Pharm. 2014 Jul 1;468(1-2):172-7. doi: 10.1016/j.ijpharm.2014.04.019. Epub 2014 Apr 13.

PMID:
24727141
17.

Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.

El-Sayed A, Boraie NA, Ismail FA, El-Khordagui LK, Khalil SA.

East Mediterr Health J. 2007 Nov-Dec;13(6):1427-37.

PMID:
18341192
18.

Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.

Al-Gousous J, Amidon GL, Langguth P.

Mol Pharm. 2016 Jun 6;13(6):1927-36. doi: 10.1021/acs.molpharmaceut.6b00077. Epub 2016 May 10.

PMID:
27139040
19.

Interaction of omeprazole with enteric-coated salicylate tablets.

Nefesoglu FZ, Ayanoglu-Dülger G, Ulusoy NB, Imeryüz N.

Int J Clin Pharmacol Ther. 1998 Oct;36(10):549-53.

PMID:
9799060
20.

Bioequivalence evaluation of two omeprazole enteric-coated formulations in humans.

Farinha A, Bica A, Pais JP, Toscano MC, Tavares P.

Eur J Pharm Sci. 1999 Mar;7(4):311-5.

PMID:
9971914

Supplemental Content

Support Center